We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

137 hedge funds and large institutions have $1.04B invested in Epizyme, Inc in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 48 increasing their positions, 43 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,230% more call options, than puts

Call options by funds: $28.9M | Put options by funds: $2.17M

12% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

5% less capital invested

Capital invested by funds: $1.1B → $1.04B (-$53.7M)

9% less funds holding

Funds holding: 151 → 137 (-14)

44% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 32

Holders
137
Holders Change
-14
Holders Change %
-9.27%
% of All Funds
2.42%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
18
Increased
48
Reduced
43
Closed
32
Calls
$28.9M
Puts
$2.17M
Net Calls
+$26.8M
Net Calls Change
-$1.54M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$14M
2
FM
Frazier Management
Washington
+$9.02M
3
Citadel Advisors
Citadel Advisors
Florida
+$7.41M
4
GIM
Granahan Investment Management
Massachusetts
+$5.58M
5
Morgan Stanley
Morgan Stanley
New York
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$11.9M
2
PC
Pier Capital
Connecticut
-$6.85M
3
MB
MPM BioImpact
Massachusetts
-$6.45M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.3M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
WS
151
Wedbush Securities
California
– -$316K -26,450 Closed
DTL
152
Dynamic Technology Lab
Singapore
– -$265K -22,251 Closed
PP
153
Paloma Partners
Connecticut
– -$265K -22,183 Closed
VF
154
Virtu Financial
New York
– -$231K -19,347 Closed
EGM
155
Engineers Gate Manager
New York
– -$215K -18,028 Closed
DA
156
Duality Advisers
Florida
– -$214K -17,920 Closed
LJAC
157
L.J. Altfest & Co
New York
– -$204K -17,079 Closed
TC
158
TwinBeech Capital
New York
– -$179K -14,972 Closed
BFM
159
Boothbay Fund Management
New York
– -$130K -10,934 Closed
MWNA
160
Marshall Wace North America
New York
– -$123K -10,358 Closed
AA
161
AlphaCentric Advisors
Puerto Rico
– -$80K -6,700 Closed
FHA
162
Flagship Harbor Advisors
Massachusetts
– -$65K -5,500 Closed
CG
163
Cutler Group
California
– -$13.6K -1,100 Closed
CAL
164
Capital Analysts LLC
Pennsylvania
– -$12K -1,000 Closed
Federated Hermes
165
Federated Hermes
Pennsylvania
– -$11K -935 Closed
CHAM
166
Clear Harbor Asset Management
Connecticut
– -$8.35K -700 Closed
ASN
167
Advisory Services Network
Georgia
– -$1.88K -152 Closed
3 4 5 6
7

EPZM Hedge Fund Activity: Q4 2020 in Review

137 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2020, worth a combined $1.04B — down 4.9% from $1.1B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of EPZM and 18 opened new positions — a net loss of 14 holders — while 43 trimmed existing stakes and 48 added.

The largest buyer was Redmile Group, adding an estimated $14M. The largest seller was Artal Group, exiting entirely with an estimated $11.9M sold.

  • 137 institutional investors held Epizyme, Inc (EPZM) as of Q4 2020, down from 151 in Q3 2020.
  • Funds reported $1.04B of Epizyme, Inc stock for Q4 2020, down 4.9% quarter-over-quarter.
  • 18 funds opened new Epizyme, Inc positions in Q4 2020 and 32 closed out, a net change of -14 holders.
  • The largest Epizyme, Inc buyer in Q4 2020 was Redmile Group, an estimated $14M added.
  • The largest Epizyme, Inc seller in Q4 2020 was Artal Group, an estimated $11.9M sold.

Based on aggregated 13F filings for Q4 2020.